RHKd Stock Overview
Offers in-patient, semi-patient, and outpatient healthcare services in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
RHÖN-KLINIKUM Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €10.15 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | -0.014 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | -59.63% |
| Change since IPO | -52.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| RHKd | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.5% | 0.8% |
| 1Y | n/a | -23.5% | 6.6% |
Return vs Industry: Insufficient data to determine how RHKd performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how RHKd performed against the UK Market.
Price Volatility
| RHKd volatility | |
|---|---|
| RHKd Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: RHKd has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RHKd's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 18,158 | Tobias Kaltenbach | www.rhoen-klinikum-ag.com |
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary
| RHKd fundamental statistics | |
|---|---|
| Market cap | €743.02m |
| Earnings (TTM) | €31.92m |
| Revenue (TTM) | €1.71b |
23.3x
P/E Ratio0.4x
P/S RatioIs RHKd overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RHKd income statement (TTM) | |
|---|---|
| Revenue | €1.71b |
| Cost of Revenue | €1.50b |
| Gross Profit | €202.27m |
| Other Expenses | €170.35m |
| Earnings | €31.92m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Mar 28, 2024
| Earnings per share (EPS) | 0.48 |
| Gross Margin | 11.85% |
| Net Profit Margin | 1.87% |
| Debt/Equity Ratio | 11.9% |
How did RHKd perform over the long term?
See historical performance and comparison